Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?

[1]  U. Hanisch,et al.  Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling , 2014, Neurological research.

[2]  J. Chapman Coagulation in Inflammatory Diseases of the Central Nervous System , 2013, Seminars in Thrombosis & Hemostasis.

[3]  M. Fehlings,et al.  Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity , 2013, Journal of neurochemistry.

[4]  Tao Jiang,et al.  Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. , 2013, Cancer letters.

[5]  M. Mrugala,et al.  Advances and challenges in the treatment of glioblastoma: a clinician's perspective. , 2013, Discovery medicine.

[6]  J. Uhm,et al.  Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. , 2013, Neuro-oncology.

[7]  M. Merchant,et al.  Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage* , 2012, The Journal of Biological Chemistry.

[8]  J. Bernaudin,et al.  Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. , 2012, Thrombosis research.

[9]  R. Monteiro,et al.  Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines. , 2012, Biochemical and biophysical research communications.

[10]  H. Hamm,et al.  Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo , 2012, Cancer.

[11]  XiaoNa Wei,et al.  An Integrated Mathematical Model of Thrombin-, Histamine-and VEGF-Mediated Signalling in Endothelial Permeability , 2011, BMC Systems Biology.

[12]  Zhi-cheng Yuan,et al.  Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas. , 2011, Pathology, research and practice.

[13]  Q. Ye,et al.  Thrombin is a therapeutic target for metastatic osteopontin‐positive hepatocellular carcinoma , 2010, Hepatology.

[14]  S. W. Schneider,et al.  The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells. , 2010, The Journal of investigative dermatology.

[15]  S. Karpatkin,et al.  Role of thrombin as a tumor growth factor , 2010, Cell cycle.

[16]  José A Fernández,et al.  Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1 , 2009, Thrombosis and Haemostasis.

[17]  G. Reiser,et al.  Protease-activated receptors in the brain: Receptor expression, activation, and functions in neurodegeneration and neuroprotection , 2007, Brain Research Reviews.

[18]  H. Hamada,et al.  Thrombin‐induced cell proliferation and platelet‐derived growth factor‐AB release from A172 human glioblastoma cells , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  J. Chapman Thrombin in inflammatory brain diseases. , 2006, Autoimmunity reviews.

[20]  V. Rumjanek,et al.  On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells , 2006, Journal of Thrombosis and Haemostasis.

[21]  D. Gurwitz,et al.  Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. , 2005, Immunobiology.

[22]  M. Mulholland,et al.  Thrombin and PAR-1-AP increase proinflammatory cytokine expression in C6 cells. , 2005, The Journal of surgical research.

[23]  S. Fisher,et al.  Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[24]  J. Bockaert,et al.  Constitutive Secretion of Protease Nexin-1 by Glial Cells and Its Regulation by G-Protein-Coupled Receptors , 2005, The Journal of Neuroscience.

[25]  T. Schallert,et al.  The role of thrombin in gliomas , 2005, Journal of thrombosis and haemostasis : JTH.

[26]  D. Gurwitz,et al.  Increased thrombin inhibition in experimental autoimmune encephalomyelitis , 2005, Journal of neuroscience research.

[27]  D. Brat,et al.  Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes , 2004, Experimental Neurology.

[28]  F. Fiorino,et al.  Thrombin and PAR‐1 acitvating peptide increase iNOS expression in cytokine‐stimulated C6 glioma cells , 2001, Journal of neurochemistry.

[29]  M. D. Del Bigio,et al.  Acute Tissue Damage After Injections of Thrombin and Plasmin into Rat Striatum , 2001, Stroke.

[30]  D. Gurwitz,et al.  Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities , 2001, Neuroreport.

[31]  T. Kubota,et al.  Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors. , 1999, Anticancer research.

[32]  E. Komives,et al.  Mechanism of Thrombin Clearance by Human Astrocytoma Cells , 1999, Journal of neurochemistry.

[33]  V. Ramakrishnan,et al.  Investigation of PAR-1-type thrombin receptors in rat glioma C6 cells with a novel monoclonal anti-PAR-1 antibody (Mab COR7-6H9) , 1998, Journal of neurocytology.

[34]  G. Reiser,et al.  Co-existence of two types of [Ca2+]i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells , 1998, Neuroscience.

[35]  R. Kalff,et al.  Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells , 1998, Neuroreport.

[36]  P. Henklein,et al.  Signaling effects of α‐thrombin and SFLLRN in rat glioma C6 cells , 1996 .

[37]  J. Bockaert,et al.  Secretion of Protease Nexin-1 by C6 Glioma Cells Is under the Control of a Heterotrimeric G Protein, Go1* , 1996, The Journal of Biological Chemistry.

[38]  N. Kawai,et al.  Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. , 1996, Journal of neurosurgery.

[39]  C. Deschepper,et al.  Production of thrombin and antithrombin III by brain and astroglial cell cultures. , 1991, Brain research. Molecular brain research.

[40]  M. Nishibori,et al.  The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma , 2009, Journal of Neural Transmission.

[41]  T. Schallert,et al.  Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. , 2005, Acta neurochirurgica. Supplement.

[42]  T. Yoshimine,et al.  Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains , 2005, Journal of Neuro-Oncology.

[43]  R. Kaufmann,et al.  Thrombin has a bimodal effect on glioma cell growth. , 1997, British Journal of Cancer.

[44]  H. Haller,et al.  Signaling effects of alpha-thrombin and SFLLRN in rat glioma C6 cells. , 1996, Journal of neuroscience research.